GrayMatters Health Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 32

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.05M

  • Investors
  • 11

GrayMatters Health General Information

Description

Developer of a health technology designed to develop a self-neuromodulation treatment based on brain biomarkers associated with mental health disorders. The company's digital therapeutics follow the self-regulation of brain processes to solve the issues related to mental health and neurologic disorders and mental healthcare professionals with a neuroscience-based technology that bridges the gaps of efficacy, safety, and accessibility for healthcare common procedure coding system and patients, enabling patients suffering from neurological disorders to treat their diseases in a hassle-free manner.

Contact Information

Website
www.graymatters-health.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Derech HaAtsmaut 82
  • Haifa 3303403
  • Israel
Primary Industry
Therapeutic Devices
Other Industries
Decision/Risk Analysis
Other Healthcare Technology Systems
Vertical(s)
Digital Health, Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • Derech HaAtsmaut 82
  • Haifa 3303403
  • Israel

GrayMatters Health Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GrayMatters Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 09-Oct-2025 $1.05M Completed Generating Revenue
8. Accelerator/Incubator 10-Oct-2024 Completed Generating Revenue
7. Later Stage VC 16-Apr-2024 Completed Generating Revenue
6. Later Stage VC (Series B) 06-Mar-2023 Completed Clinical Trials - General
5. Accelerator/Incubator 23-Sep-2022 Completed Clinical Trials - General
4. Early Stage VC (Series A1) 11-Jan-2022 Completed Clinical Trials - General
3. Grant 06-Oct-2021 Completed Clinical Trials - General
2. Accelerator/Incubator 01-Jan-2021 $3.55M Completed Product In Beta Test
1. Seed Round 04-Mar-2020 $3.55M $3.55M Completed Product In Beta Test
To view GrayMatters Health’s complete valuation and funding history, request access »

GrayMatters Health Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Preferred A1
Preferred A
To view GrayMatters Health’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

GrayMatters Health Patents

  • 23

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 19

    Pending

  • Expiring in next 12 mo

GrayMatters Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026190776-A1 Mental strategy representation Pending 09-Mar-2025
WO-2026150411-A1 Stress disorder predisposition Pending 12-Jan-2025
WO-2026139955-A1 Subject observations Pending 24-Dec-2024
WO-2026033515-A1 Neurofeedback learning Pending 04-Aug-2024
WO-2025257822-A1 Brain network activity Pending 09-Jun-2024 A61B5/378
To view GrayMatters Health’s complete patent history, request access »

GrayMatters Health Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GrayMatters Health Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Endless Frontier Labs Accelerator/Incubator Minority
28DIGITAL Accelerator/Incubator
J-Impact Impact Investing Minority
J-Ventures Venture Capital Minority
Otsuka Medical Devices Corporation Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

GrayMatters Health FAQs

  • When was GrayMatters Health founded?

    GrayMatters Health was founded in 2018.

  • Where is GrayMatters Health headquartered?

    GrayMatters Health is headquartered in Haifa, Israel.

  • What is the size of GrayMatters Health?

    GrayMatters Health has 32 total employees.

  • What industry is GrayMatters Health in?

    GrayMatters Health’s primary industry is Therapeutic Devices.

  • Is GrayMatters Health a private or public company?

    GrayMatters Health is a Private company.

  • What is GrayMatters Health’s current revenue?

    The current revenue for GrayMatters Health is .

  • How much funding has GrayMatters Health raised over time?

    GrayMatters Health has raised $19M.

  • Who are GrayMatters Health’s investors?

    Endless Frontier Labs, 28DIGITAL, J-Impact, J-Ventures, and Otsuka Medical Devices are 5 of 11 investors who have invested in GrayMatters Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process